Brief: Sedana Medical Q1 Sales SEK 48.8 Million
25/04/2024 06:24
Apr 25 (Reuters) - Sedana Medical Q1 sales SEK 48.8 million. * Q1 net income SEK 20.7 million * Q1 EBIT margin -13% * Q1 cash flow from operating activities SEK 8.4 million * Q1 EBITDA SEK -1 million * Q1 adjusted EPS SEK 0.21
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln